Strategic partnerships Infervision has established collaborations with over 1000 hospitals globally and long-term academic research ties, presenting a ready-made entry point for joint ventures, pilot programs, and enterprise-scale AI implementations across hospitals and government healthcare networks.

Clinical AI breadth A diverse AI suite spanning disease screening, diagnosis, interventional support, patient management, and research education enables cross-sell of modular solutions to radiology, oncology, cardiology, and cerebrovascular departments within large health systems.

Public market momentum Past public listing activity and high-profile funding rounds, including strategic investments from major banks, signal credibility and investor validation that can help in approaching national health authorities and larger hospital networks for approvals and scale deployments.

Global health footprint Global deployments across North America, Europe, and Asia, combined with multinational partnerships, create opportunities to tailor regional regulatory-compliant deployments, accelerate contract negotiations, and address hospital modernization initiatives.

Research-driven value Active involvement in AI research platforms and collaborations with leading radiology institutions positions Infervision as a partner for research-focused pilots, real-world evidence programs, and advanced imaging studies that can unlock funded projects and expanded use cases.